Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2/3 1Phase 1 1

Status

Completed 4Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 5Observational 2

Sponsor

Conditions

Pain 11Neoplasms 8Cancer Pain 7Pain, Postoperative 2Pain, Intractable 2Lymphoma, Follicular 2Leukemia 2Waldenstrom Macroglobulinemia 1Vomiting 1Urinary Bladder Neoplasms 1Thrombocythemia, Essential 1Stomatitis 1Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Squamous Cell Carcinoma of Head and Neck 1Spinal Surgery 1Sleep Wake Disorders 1Signs and Symptoms 1Sezary Syndrome 1Rectal Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Postoperative Complications 1Polycythemia Vera 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Pathologic Processes 1Pain Related to Cancer 1Opioid-Related Disorders 1Neurologic Manifestations 1

Interventions

Morphine 16Oxycodone 14Fentanyl 10Methadone 7nabiximols 5Lidocaine 5Acetaminophen 5resiniferatoxin 4Hydromorphone 4Ethanol 4Acupuncture Therapy 4Transcutaneous Electric Nerve Stimulation 3Buprenorphine 3Transcranial Direct Current Stimulation 2Tapentadol 2Surveys and Questionnaires 2Standard of Care 2Sodium Bicarbonate 2Radiosurgery 2Radiofrequency Ablation 2Pharmaceutical Services 2Naloxone 2Ketamine 2Electroacupuncture 2Dronabinol 2Control Groups 2Analgesics, Opioid 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tanezumab 1rofecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Cancer Pain × Methadone × Clear all
NCT05265442 2024-10-31

DUNE

RECORDATI GROUP

Completed
136 enrolled

Cancer Pain

NCT05325164 2022-12-05

METHADOPT

Ottawa Hospital Research Institute

Phase 3 Withdrawn

Cancer Pain, Adenocarcinoma, Neoplasms

NCT00125294 2017-09-25

Sublingual Methadone for the Management of Cancer Breakthrough Pain

AHS Cancer Control Alberta

Phase 1 Completed
10 enrolled

Cancer Pain, Neoplasms, Pain, Breakthrough Pain

NCT00634010 2016-05-09

Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain

M.D. Anderson Cancer Center

Phase 3 Terminated
36 enrolled 6 charts

Cancer Pain

NCT01946555 2016-04-14

RER

Mario Negri Institute for Pharmacological Research

Completed
150 enrolled

Cancer Pain, Neoplasms, Neuralgia

NCT02335398 2015-01-09

Development and Evaluation of a Methadone Protocol for Severe Chronic Pain Management

Mahidol University

Phase 4 Completed
34 enrolled

Cancer Pain, Chronic Pain

NCT00525967 2007-09-06

Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain

Faculdade de Medicina do ABC

Phase 2/3 Unknown
50 enrolled

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡